Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Immunogenic cell death in cancer: targeting necroptosis to induce antitumour immunity
Pascal Meier, Arnaud J. Legrand, Dieter Adam, et al.
Nature reviews. Cancer (2024) Vol. 24, Iss. 5, pp. 299-315
Closed Access | Times Cited: 99

Showing 26-50 of 99 citing articles:

Extracellular Vesicle‐Based Antitumor Nanomedicines
Mingfeng Li, Yanfei Liu, Fei Liu, et al.
Advanced Healthcare Materials (2025)
Closed Access
Harnessing Prazosin for Tumors: Liposome Hybrid Nanovesicles Activate Tumor Immunotherapy via Autophagy Inhibition
Xinyang Xuanyuan, Wenshang Liu, Min Jiang, et al.
Biomaterials (2025) Vol. 319, pp. 123184-123184
Closed Access
Glucose Metabolism‐Targeted Poly(amino acid) Nanoformulation of Oxaliplatin(IV)‐Aspirin Prodrug for Enhanced Chemo‐Immunotherapy
Jiazhen Yang, Tianqi Su, Qinqi Wang, et al.
Advanced Materials (2025)
Closed Access
CD44-targeting and ZIF-8-gated gold nanocage for programmed breast cancer therapy through Pt-induced immunogenic cell death
Xin Li, Fei Xiong, Xudong Cao, et al.
Chinese Chemical Letters (2025), pp. 110970-110970
Closed Access
An immunogenic cell death dual-nanoamplifier for the reverse of chemotherapy resistance and immune escape in metastatic colon cancer
Fangming Zhang, Kexin Cui, Yixuan Zhou, et al.
Nano Today (2025) Vol. 62, pp. 102678-102678
Closed Access
An all-in-one polymeric nanomedicine as in situ cascade cancer vaccine for potent cancer immunotherapy
Bin Xu, Hengliang Hou, Weijia Xu, et al.
Nano Today (2025) Vol. 62, pp. 102691-102691
Closed Access
Targeting the CXCR7 pathway with TC14012 to inhibit endothelial necroptosis and lung cancer metastasis
Huifeng Hao, Wenjia Tian, Jingjing Gong, et al.
Biochemical Pharmacology (2025), pp. 116852-116852
Closed Access
Biomimetic Self-Oxygenated Immunoliposome for Cancer-Targeted Photodynamic Immunotherapy
Yucheng Tang, Tiantian Tang, Yongjiang Li, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 2743-2759
Open Access
A “CPApoptosis” nano-actuator switches immune-off solid tumors to immune-on for fueling T-cell- based immunotherapy
Ying Luo, Yi Wang, Bo Liu, et al.
Theranostics (2025) Vol. 15, Iss. 9, pp. 3797-3820
Open Access
Aggregation induced emission luminogen bacteria hybrid bionic robot for multimodal phototheranostics and immunotherapy
Liwei Zhu, Guangjie Song, Wentian Zhang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access
Prunin: An Emerging Anticancer Flavonoid
Juie Nahushkumar Rana, Sohail Mumtaz
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 6, pp. 2678-2678
Open Access
Disrupt Mitochondrial Proton Gradients via Flexoelectric Catalysis to Deplete Tumor Energy and Enhance Immunotherapy
Yihan Fu, Zichuang Xu, H. F. Liu, et al.
Advanced Functional Materials (2025)
Closed Access
Injectable Magnetic-Nanozyme Based Thermosensitive Hydrogel for Multimodal DLBCL Therapy
Min Yan, Jingcui Peng, Haoan Wu, et al.
Gels (2025) Vol. 11, Iss. 3, pp. 218-218
Open Access
Transforming cancer treatment: integrating patient-derived organoids and CRISPR screening for precision medicine
Ziyi Zhu, John Paul Shen, Paul Chi-Lui Ho, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access
Regulation of immunogenic cell death and potential applications in cancer therapy
Kun Fang, Shuai Yuan, Xue Zhang, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
Nanotechnology in the perioperative treatment of head and neck cancer: application and outlook
Junjie Zhou, Yuanming Feng, Ming Zhao, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access
CYPD limits HR+ mammary carcinogenesis in mice
Lorenzo Galluzzi, Aitziber Buqué, Manuel Beltrán‐Visiedo, et al.
Research Square (Research Square) (2025)
Closed Access
Neuropilin-1: A Multifaceted Target for Cancer Therapy
Sai Manasa Varanasi, Yash Gulani, Hari Krishnareddy Rachamala, et al.
Current Oncology (2025) Vol. 32, Iss. 4, pp. 203-203
Open Access
Genomic and Immune Profiling of Esophageal Squamous Cell Carcinoma Undergoing Neoadjuvant Therapy Versus Upfront Surgery Identifies Novel Immunogenic Cell Death‐Based Signatures for Predicting Clinical Outcomes
Peidong Song, Wenze Tian, Yujia Zheng, et al.
MedComm (2025) Vol. 6, Iss. 4
Open Access
Metabolism-Related Programmed Cell Death: Unveiling Prognostic Biomarkers, Immune Checkpoints, and Therapeutic Strategies in Ovarian Cancer
Mengdi Fu, Hao Wu, Peng Peng, et al.
Cancer Investigation (2025), pp. 1-22
Closed Access
The Role of Post-Translational Modifications in Necroptosis
Hao Xiao, Zang Chao Han, Min Xu, et al.
Biomolecules (2025) Vol. 15, Iss. 4, pp. 549-549
Open Access
Dynamics of inflammatory signals within the tumor microenvironment
Hala Issa, Lokjan Singh, Kok‐Song Lai, et al.
World Journal of Experimental Medicine (2025) Vol. 15, Iss. 2
Closed Access
A Mitochondrion‐Targeted NIR‐II Modulator for Synergistic Ferroptosis–Immunotherapy
Miao Wang, Qihang Ding, Wuyue Su, et al.
Small (2025)
Closed Access
Rosmarinus officinalis L. as Fascinating Source of Potential Anticancer Agents Targeting Aromatase and COX-2: An Overview
Adriana Gargano, Ilario Greco, Carmine Lupia, et al.
Molecules (2025) Vol. 30, Iss. 8, pp. 1733-1733
Open Access
Immunogenic Cell Death and Metabolic Reprogramming in Cancer: Mechanisms, Synergies, and Innovative Therapeutic Strategies
Jie Jiang, Ying Yan, Chunhui Yang, et al.
Biomedicines (2025) Vol. 13, Iss. 4, pp. 950-950
Open Access

Scroll to top